Study Looks at Risk Factors for Rupture or Bleeding of Arachnoid Cysts in Children

Larger Arachnoid Cysts and Head Trauma Are Main Risks, Reports Study in Neurosurgery

Philadelphia, Pa. (May 21, 2013) – Arachnoid cysts are a common type of brain lesion that is usually harmless, but with a risk of rupture or bleeding. A new study identifies risk factors for rupture or bleeding in children with “incidentally” detected arachnoid cysts, reports the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Risk is higher for children with larger cysts and a recent history of even mild head trauma, according to the report by Dr. Jay Riva-Cambrin of University of Utah, Salt Lake City.

What Factors Increase the Risk of Ruptured Arachnoid Cysts?

Arachnoid cysts are benign (not cancerous) fluid-filled sacs that develop between the brain and the arachnoid membrane covering it. Most arachnoid cysts are “primary,” that is, present from birth. They are relatively common, estimated to be present in about 1 out of 40 children.

With modern brain imaging studies, arachnoid cysts are often detected “incidentally”—during imaging tests performed for another reason. Although the cysts usually cause no harm, if they rupture (break open) or bleed, they can cause potentially serious problems requiring emergency treatment.

In their study, Dr. Riva-Cambrin and colleagues sought to identify risk factors for rupture and bleeding in children with arachnoid cysts. Fourteen children with ruptured cysts treated at the authors’ hospital from 2005 to 2010 were matched to 28 children with known cysts but not rupture or bleeding.

The 14 ruptured/bleeding cysts accounted for six percent of all arachnoid cysts detected at the authors’ hospital. The patients were ten boys and four girls, average age six years. Most children with ruptured/bleeding cysts had headache and other symptoms related to increased pressure within the skull (intracranial pressure).

One important risk factor was larger cyst diameter. Rupture and/or bleeding occurred in 69 percent of cysts measuring five centimeters or larger, compared to 17 percent of smaller cysts. Risk was estimated to be 16 times greater for cysts of five centimeters or larger.

Eighty-six percent of children with ruptured/bleeding cysts had a history of recent head trauma, compared to 14 percent with unruptured cysts. In nearly every case, the head trauma was minor and “seemingly trivial”—such as a fall from a low height. Yet risk of cyst rupture/bleeding was 25 times higher for these children.

Findings May Aid in Patient Counseling

Some previous reports suggested a higher risk of arachnoid cyst rupture or aneurysm at higher altitudes. However, the rupture rate at the authors’ Salt Lake City hospital appeared no higher than at hospitals at lower elevations.

Ten of the children with ruptured/bleeding cysts required surgery; two children needed shunt placement to manage continued problems with fluid in the skull (hydrocephalus). None of the children died or had major disability.

As more children with arachnoid cysts are identified, neurosurgeons need the best possible information on risk factors for rupture or bleeding. The risk that an arachnoid cyst will rupture or bleed has been estimated somewhere between two and five percent. Because most cysts are still unidentified, the true risk is almost certainly even lower.

The new results suggest that larger cysts and recent head trauma are key risk factors for arachnoid cyst rupture or bleeding. The researchers hope their findings will be useful in discussing the risks and follow-up for the growing number of children discovered to have arachnoid cysts.

Dr. Riva-Cambrin and colleagues acknowledge that the increased risk of cyst rupture/bleeding after mild head trauma is “potentially alarming.” But they note that such injuries are extremely common in children’s daily lives. While parents should be aware of this risk, the authors believe there’s no reason to restrict sports or other activities for most children with arachnoid cysts.

About Neurosurgery

Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Neurology, Publications, Surgery - Neurosurgery | Leave a comment

Can High-Dose Statins Improve Outcomes after Aneurysm-Related Stroke?

Planned Trial Will Evaluate Simvastatin Treatment for Aneurysmal Subarachnoid Hemorrhage, Reports Neurosurgery

Philadelphia, Pa. (May 21, 2013) – Can treatment with high doses of a cholesterol-lowering statin drug improve outcomes for patients with stroke caused by rupture and bleeding of brain aneurysms? An ongoing clinical trial will soon find out, according to an article in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Together with other research already underway, the trial will help to determine whether statin medications are effective in limiting damage to the brain in patients with aneurysmal subarachnoid hemorrhage (SAH). The lead investigator is Dr. George Kwok Chu Wong of Chinese University of Hong Kong.

Statins Show Promise in Treatment of Aneurysmal SAH

Dr. Wong and colleagues outline their plans for a study to evaluate the benefits of high-dose simvastatin for patients with SAH caused by a ruptured aneurysm. Subarachnoid hemorrhage is a life-threatening type of stroke in which there is bleeding into the brain. It most commonly occurs when an aneurysm—a weak spot in one of the blood vessels supplying the brain—ruptures or breaks.

Experimental studies, including preliminary studies in humans, have suggested that simvastatin may have treatment benefits for SAH. Statins have known “neuroprotective” effects in brain tissue. A recent summary of the evidence suggests that simvastatin—a widely prescribed cholesterol-lowering drug—can reduce brain injury caused by delayed ischemia (decreased blood flow). Delayed ischemia is a major contributor to death and disability after SAH.

Based on the evidence, statins have been recommended as part of routine treatment for aneurysmal SAH. “However,” Dr. Wong and coauthors write, “no clinical data are available to answer whether a high-dose regimen is more effective than a normal-dose regimen, even though the biochemical actions and related neuroprotective mechanisms are thought to be dose-related.”

Trial to Compare High vs Low Doses of Simvastatin

The planned study will compare high-dose versus low-dose simvastatin for patients with aneurysmal SAH. Both the higher and lower doses—80 and 40 milligrams per day—are commonly used in treating high cholesterol. Patients will be randomly assigned to either the higher or lower dose; treatment will start within 96 hours after stroke onset and continue for three weeks.

The main objective will be to see if there’s any difference in the rate of delayed ischemia causing brain damage between groups. The study will also look for between-group differences in neurological function and disability, and evaluate the cost-effectiveness of high- versus low-dose simvastatin treatment. Safety assessment will include special attention to the risk of certain statin-related complications in the higher-dose group.

Dr. Wong and colleagues have been enrolling patients in their trial, and expect to have the results soon. They note that another trial is being conducted to compare normal-dose simvastatin with inactive placebo for patients with SAH after ruptured aneurysm. They conclude, ” When the results are interpreted together, the research question of a possible beneficial effect of high-dose simvastatin in acute aneurysmal subarachnoid hemorrhage could be answered.”

About Neurosurgery

Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Neurology, Publications, Surgery - Neurosurgery | Leave a comment

Wolters Kluwer Health Receives 13 Awards from the American Society of Healthcare Publication Editors (ASHPE) for Editorial and Design Excellence

Eight Lippincott Williams & Wilkins Published Journals Earn 4 Gold, 3 Silver, and 6 Bronze Awards

Philadelphia, PA (May 20, 2013) –Wolters Kluwer Health is pleased to announce that its Lippincott Williams & Wilkins (LWW) published journals won 13 ASHPE awards in 10 categories. ASHPE’s annual awards competition recognizes member articles and publications for editorial, design, print and online award categories.

“It’s a tremendous honor to be recognized year after year for delivering high-quality publications that have become synonymous in the industry with quality, depth, and impact,” said Jayne Marks, Vice President Publishing, Wolters Kluwer Health, Medical Research. “I am extremely proud of the editorial, design, and publishing teams for their hard work and continued commitment to excellence.”

This year, LWW received four gold awards: Best Peer-Reviewed Journal – Plastic and Reconstructive Surgery, published on behalf of the American Society of Plastic Surgeon; Best New Department – Emergency Medicine News; Best Profile – Neurology Now, published on behalf of the American Academy of Neurology; and Best Regular Department – OR Nurse.

See below for the complete list of 2013 ASHPE awards received by LWW journals:

Best How-to Article:

  • Bronze: OR Nurse 2012, “Identifying Substance Use Disorders in the OR” (July 2012)

Best New Department:

  • Gold: Emergency Medicine News, “At Your Defense” (July, August, September 2012)

Best Profile:

  • Gold: Neurology Now, “Rocket Man: Astronaut Rich Clifford’s Journey with Parkinson’s Disease” (April/May 2012), Published on behalf of the American Academy of Neurology (AAN)

Best Regular Department:

  • Gold: OR Nurse 2012, “Smart Management” (January, March, September 2012)
  • Bronze: Emergency Medicine News, “Diagnosis Deconstructed” (January, June, September 2012)

Best Single News Article:

  • Bronze: Neurology Today, “Elevated Mortality Associated with Neurodegenerative Disease Reported Among Football Players—What the Study Says, What it Does Not Say” (October 4, 2012), Published on behalf of the American Academy of Neurology (AAN)

Best Cover Illustration:

  • Silver: American Journal of Nursing, “The 2012 Republican and Democratic Health Care Platforms” (October 2012)

Best Opening Page/Spread Photo:

  • Bronze: Nursing2012, “An Inside Look at Correctional Health Nursing” (April 2012)

Best Blog:

  • Silver: American Journal of Nursing, “Off the Charts”
  • Bronze: Emergency Medicine News, “M2E Too! Mellick’s Multimedia EduBlog”

Best Custom Publication:

  • Silver: Neurology Now (August/September, October/November, December 2012), Published on behalf of the American Academy of Neurology (AAN)
  • Bronze: Heart Insight (May, August, November 2012), Published on behalf of the American Heart Association (AHA)

Best Peer-Reviewed Journal:

  • Gold: Plastic and Reconstructive Surgery (September/November, 2012), Published on behalf of the American Society of Plastic Surgeons (ASPS).

About American Society of Healthcare Publication Editors (ASHPE)

The American Society of Healthcare Publication Editors (ASHPE) is dedicated to enhancing the knowledge and skills of healthcare publication editors, and thereby expanding their value to, and contribution of, the publications they serve. ASHPE is committed to fostering the highest ethical standards in management; rewarding excellence in publications development and editorial performance; and serving as an authority on evolving trends in the healthcare publishing sector.

About Wolters Kluwer Health

Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, Medknow, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Health Language®, Lexicomp® and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Cardiology, Emergency Medicine, Media, Neurology, Nursing, Publications, Surgery - Plastic and Reconstructive | Leave a comment

Telerehabilitation Allows Accurate Assessment of Patients with Low Back Pain

Skype Assessments Agree Well with In-Person Exams, Reports Study in Spine

Philadelphia, Pa. (May  20, 2013) – A new “telerehabilitation” approach lets physical therapists assess patients with low back pain (LBP) over the Internet, with good accuracy compared with face-to-face examinations, reports a study in the May 15 issue of Spine.  The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Taking advantage of Skype and other widely-used services may make telerehabilitation a more feasible alternative to in-person clinic visits, according to the new research by Prof. Manuel Arroyo-Morales and colleagues of University of Granada, Spain.  They believe their results “give preliminary support to the implementation of web-based LBP assessment systems using video recordings that can be evaluated by different therapists.”

Can Back Pain Assessments Be Performed Over the Internet?

The researchers designed and evaluated a web-based telerehabilitation system for performing routine clinical assessments of patients with LBP.  The telerehabilitation setup operated across a low-bandwidth Internet connection between two personal computers equipped with webcams.

The system included the popular Skype videoconferencing service, allowing the patient and physical therapist could see and talk to each other in real time.  The therapist guided the patient in performing specific movements, and captured video clips for analysis using video motion analysis software (Kinovea).  The therapist and patient were also able to complete standard back pain questionnaires using the web-based system.

Fifteen patients with chronic LBP underwent two assessments in random order:  once face-to-face and once using the telerehabilitation setup.  Accuracy was assessed by comparing the results of telerehabilitation assessment with those of in-person assessment.

The results showed good agreement between the two evaluations, supporting the use of telerehabilitation for clinical assessment of LBP.  There was good correlation for measures made on video motion analysis, such as spine mobility and back muscle endurance; as well as questionnaire-based assessments such as disability, pain, and health-related quality of life.

Skype and Other Tools Make Telerehabilitation More Feasible

The telerehabilitation setup showed consistent results for the same therapist at different times (intra-rater reliability) as well as for assessment by independent therapists (inter-rater reliability).

There is growing interest in Internet-based systems for assessment of patients with musculoskeletal disorders.  Telerehabilitation approaches could be especially valuable for patient in rural or remote areas, who don’t have easy access to healthcare providers.

In the past, the use of telerehabilitation was limited by high equipment costs.  The new study shows the successful use of telerehabilitation using widely available and familiar technology, including the use of free software such as Skype.

The telerehabilitation system evaluated in the new study may be useful in assessing patients with the very common problem of LBP, showing good agreement with the results of face-to-face assessment.  However, there are still some factors limiting more widespread use—including the need for “potentially unwieldy” security software to protect patient privacy.

Prof. Arroyo-Morales and coauthors also note that many patients who would otherwise have been eligible for the study weren’t included because of a lack of familiarity and experience with computers.  The researchers call for further studies in larger groups of patients—focusing on those who don’t have easy access to in-person evaluations.

About Spine

Recognized internationally as the leading journal in its field, Spine (www.spinejournal.com) is an international, peer-reviewed, bi-weekly periodical that considers for publication original articles in the field of spine. It is the leading subspecialty journal for the treatment of spinal disorders. Only original papers are considered for publication with the understanding that they are contributed solely to Spine.  According to the latest ISI Science Citation Impact Factor, Spine is the most frequently cited spinal deformity journal among general orthopaedic journals and subspecialty titles.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Neurology, Physical Therapy, Publications | Leave a comment

Study Supports ‘Aggressive’ Treatment for Posterior Fossa Hematoma in Newborns

Good Long-Term Outcomes after Surgery in Most Infants with Rare Condition Linked to Difficult Birth, Reports Neurosurgery

Philadelphia, Pa. (May 20, 2013) – Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there’s an excellent chance of good long-term outcomes even in severe cases of PFSDH, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The results support an “aggressive” approach to evaluation and treatment—including surgery, if necessary—in even very severe cases of PFSDH in newborns, according to Dr. Thomas Blauwbomme of the Hôpital Necker-Enfants Malades, Paris, and colleagues.

Good Results of Surgery in Newborns with PFSDH…

Posterior fossa subdural hematoma is a potentially life-threatening condition in which a collection of blood (hematoma) occurs in an area at the base of the skull (posterior fossa). Pressure on the respiratory and cardiovascular centers in the brainstem can lead to serious disability or death. Less than 100 cases of PFSDH in newborns have ever been reported in the medical literature. “Excessive fetal head molding during the delivery process is the most commonly recognized cause,” the researchers write.

To clarify the treatment and outcomes of this rare condition, Dr. Blauwbomme and colleagues analyzed 16 newborns with PFSDH seen at their children’s hospital neurosurgery department since 1985. Most of the infants had difficult deliveries, such as use of forceps or breech birth.

Symptoms developed within the first day after birth in nine infants and in a few days to weeks in seven. Early symptoms were generally related to brainstem compression, while delayed symptoms were related to increased pressure within the skull (intracranial pressure).

All infants were admitted to intensive care immediately after PFSDH was diagnosed. Eleven infants underwent surgery when their symptoms did not resolve with medical treatment. In most cases, surgery consisted of a careful procedure to wash out the hematoma in the posterior fossa area. In some infants, external drainage of the hematoma was possible.

…With Good Outcomes at Long-Term Follow-Up

In all cases, surgery was successful in eliminating the hematoma and normalizing intracranial pressure. Two infants required shunt placement to keep fluid from building up in the skull (hydrocephalus). All 16 infants survived.

On long-term follow-up, five of the children had neurological deficits, which were severe in one case. However, the rest had relatively minor neurological abnormalities, such as partial hearing loss or problems with eye movement (oculomotor palsy).

Most patients with who were followed up to adolescence or young adulthood were attending normal school or independently employed. The changes of such good outcomes appeared lower for patients whose PFSDH involved a part of the brain called the cerebellum.

Because PFSDH is so rare, neurosurgeons have little experience with or information about its treatment and long-term outcomes. The new study suggests that, with appropriate evaluation and treatment—including surgery, if needed—most infants with this condition will survive with good long-term neurological functioning.

Dr. Blauwbomme and coauthors emphasize that successful treatment and good long-term outcomes are possible even in the most severely affected infants with PFSDH. They conclude, “Initial aggressive resuscitation should be performed even in cases of initial severe brainstem dysfunction because of the good long-term neurological outcome.”

About Neurosurgery

Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Neurology, Publications, Surgery - Neurosurgery | Leave a comment

Women with Chronic Physical Disabilities Are No Less Likely to Bear Children

Health Care Professionals Should Prepare for Increased Numbers of Pregnant Women with Disabilities, Suggests Study in Medical Care

Philadelphia, Pa. (May 16, 2013) – Like the general public, health care professionals may hold certain stereotypes regarding sexual activity and childbearing among women with disabilities. But a new study finds that women with chronic physical disabilities are about as likely as nondisabled women to say they are currently pregnant, after age and other sociodemographic factors are taken into account. The findings are reported in the June issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Health care professionals can expect—and should prepare for—an increase in the number of physically disabled women requiring care during pregnancy, according to the study by Dr Lisa I. Iezzoni of Massachusetts General Hospital, Boston, and colleagues. They believe their findings “refute long-held stereotypes about the reproductive choices and activities of women with chronic physical disabilities.”

‘Women with Chronic Physical Disabilities Do Become Pregnant…’

The researchers analyzed nationally representative survey data on 48,000 U.S. women of childbearing age (18 to 49 years).  Women were asked about various forms of chronic physical disability and whether they were currently pregnant.  The study focused on physical health conditions causing difficulties doing certain activities; it did not address disability caused by mental or emotional problems, vision or hearing loss, or pregnancy.

Overall, 12.7 percent of women surveyed had some type of chronic physical disability. Compared to nondisabled women, those with physical disabilities were older, more likely to be black, more likely to divorced or separated, and less likely to have a high-school education. Women with disabilities were also less likely to be employed and had lower incomes.

Current pregnancy was reported by 3.5 percent of the women surveyed. The pregnancy rate for women with chronic physical disabilities was 2.0 percent, compared to 3.8 percent for nondisabled women. After adjustment for demographic and social factors, the pregnancy rate among physically disabled women was only 17 percent lower than that in nondisabled women—the difference was not statistically significant.

Women with more severe physical disabilities did have lower reported pregnancy rates.  However, even in the most severe disability category, 1.5 percent of women said they were currently pregnant.

‘…And Their Numbers Will Likely Grow”

The study is one of the first to use population-based data to examine the reproductive choices and experiences of women with chronic physical disabilities.  Dr Iezzoni and coauthors write, “Historically women with physical disabilities have confronted stigmatization concerning their reproductive and sexual health.”

Extrapolated to the entire country, the results suggest that nearly 164,000 U.S. women with chronic physical disabilities are pregnant at any given time—including 44,000 women with severe disabilities.  The researchers write.  “These figures are sufficiently large to merit serious attention, especially since the number of women of reproductive age with chronic physical disabilities will rise in coming decades,” as part of a general trend toward increased numbers of people living with disabilities.

“Women with chronic physical disabilities do become pregnant, and their numbers will likely grow.”  Dr Iezzoni and coauthors conclude. “Whether obstetricians, nurse midwives, and other clinicians who care for pregnant women—and clinicians who provide preconception services and postpartum care—have sufficient training to serve women with chronic physical disabilities is unknown and requires additional research to explore.”

About Medical Care

Rated as one of the top ten journals in health care administration, Medical Care is devoted to all aspects of the administration and delivery of health care.  This scholarly journal publishes original, peer-reviewed papers documenting the most current developments in the rapidly changing field of health care.  Medical Care provides timely reports on the findings of original investigations into issues related to the research, planning, organization, financing, provision, and evaluation of health services.  In addition, numerous special supplementary issues that focus on specialized topics are produced with each volume.  Medical Care is the official journal of the Medical Care Section of the American Public Health Association

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Family Medicine, General Practice, and Primary Care, Internal Medicine, Publications | Leave a comment

Exercise for Patients with Major Depression—What Kind, How Intense, How Often?

Journal of Psychiatric Practice Provides Guidance for Clinicians on Prescribing Exercise for Depressed Patients

Philadelphia, Pa. (May 10, 2013) – Exercise has been shown to be an effective treatment for major depressive disorder (MDD), both when used alone and in combination with other treatments. There’s now sufficient research data to provide specific guidance on how to prescribe exercise for depressed patients, according to a report in the May Journal of Psychiatric Practice®The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

“Despite the substantial evidence supporting the use of exercise in the treatment of MDD, previous studies have not provided a clear indication of the proper dose of exercise needed to elicit an antidepressant effect,” write Chad Rethorst, PhD, and Madhukar Trivedi, MD, of the Department of Psychiatry at the University of Texas Southwestern Medical Center, Dallas.  To fill this gap, the authors reviewed available data from randomized controlled trials, with the goal of developing specific and detailed recommendations for clinicians on how to prescribe exercise for their patients with MDD.

Exercise for Major Depression—Evidence of Effectiveness

Randomized trials have shown that exercise is effective in reducing depressive symptoms in patients with MDD, on its own and in conjunction with other treatments, such as antidepressant medication and/or psychotherapy.  Exercise may help to meet the need for cost-effective and accessible alternative therapies for depressive disorders—particularly for the substantial number of patients who don’t recover with currently available treatments.

Based on the available data, aerobic exercise is the preferred form of exercise for patients with MDD—although there is also support for resistance training, Drs Rethorst and Trivedi note.   In terms of session frequency and duration, they recommend that patients participate in three to five exercise sessions per week, for 45 to 60 minutes per session.

In terms of intensity, for aerobic exercise, they recommend achieving a heart rate that is 50 to 85 percent of the individual’s maximum heart rate (HRmax). For resistance training, they recommend a variety of upper and lower body exercises―three sets of eight repetitions at 80 percent of 1-repetition maximum (RM—that is, 80 percent of the maximum weight that the person can lift one time).

Data suggest that patients may experience improvement in depressive symptoms as little as four weeks after starting exercise.  However, Drs Rethorst and Trivedi emphasize that the exercise program should be continued for at least ten to twelve weeks to achieve the greatest antidepressant effect.

Some people have questioned whether patients with MDD will be willing to participate in an exercise program.  But Drs Rethorst and Trivedi note that, in the studies they reviewed, only about fifteen percent of patients dropped out of exercise programs—comparable to dropout rates in studies of medications and psychotherapy.

The authors discuss strategies that may help improve adherence to exercise programs, such as consulting patients about their preferred types of exercise and providing individualized educational materials and feedback.  They also provide some practical tips for clinicians on how to estimate exercise intensity using readily available information.

Even if the depressed patient can’t reach the target intensity and frequency levels, exercise can still be helpful.  “Taken as a whole, these findings suggest that exercise doses below the current recommendations may still be beneficial for patients with MDD,” Drs Rethorst and Trivedi add.  “Therefore, clinicians should encourage patients to engage in at least some exercise, even if they do not exercise enough to meet current public health recommendations.”

About Journal of Psychiatric Practice

Journal of Psychiatric Practice®, a peer reviewed journal, publishes reports on new research, clinically applicable reviews, articles on treatment advances, and case studies, with the goal of providing practical and informative guidance for clinicians. Mental health professionals will want access to this journal­—for sharpening their clinical skills, discovering the best in treatment, and navigating this rapidly changing field. John M. Oldham, MD, is the editor in chief and past president of the American Psychiatric Association.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Exercise Science, Psychiatry, Psychology and Addiction Medicine, Publications | Leave a comment

Methylphenidate ‘Normalizes’ Activation in Key Brain Areas in Kids with ADHD

Functional MRI Studies Help in Understanding How Stimulant Medications Work in ADHD, As Reported in the Harvard Review of Psychiatry

Philadelphia, Pa. (May 9, 2013) – The stimulant drug methylphenidate “normalizes” activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of PsychiatryThe journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A. Moore, PhD, and colleagues of the University of Massachusetts Medical School.  They write, “In most cases, this increase ‘normalized’ activation of at least some brain areas to levels seen in typically developing children.”

How Do ADHD Medications Affect the Brain in ADHD Patients?

In a research review, Dr Moore and colleagues identified nine previous studies using fMRI to study patterns of brain activation in response to a single dose of methylphenidate.  Perhaps best known by the brand name Ritalin, methylphenidate is a common and effective treatment for ADHD.  “Although methylphenidate has been shown to significantly improve the behavioral symptoms associated with ADHD, both the mechanism behind its therapeutic effect and its direct effects on brain function are unknown,” the researchers write.

The studies evaluated methylphenidate-induced fMRI changes in various brain areas, as the participants performed different types of tasks.  Most of the studies included adolescent boys with ADHD, along with matched groups of young people without ADHD.

Methylphenidate altered activation patterns in widely distributed areas of the brain in ADHD patients, the results showed.  The main brain areas involved were the frontal lobes, the basal ganglia, and cerebellum:  “Abnormalities in these regions have all been implicated in patients with ADHD,” Dr Moore and coauthors write.

Different areas were activated during different types of fMRI tasks.  Several studies assessed performance on “inhibitory control” tasks—the ability to control certain types of accustomed (“prepotent”) responses.  In three out of five studies, methylphenidate “at least partially normalized” brain activation in ADHD patients, compared to healthy young people.

Different Tasks Affect Different Brain Areas

A few studies showed similar normalization of brain responses with methylphenidate on tasks of selective attention and time perception—although not on tasks evaluating working memory.  Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks.  During selective attention tasks, a wider range of brain areas were affected.

Since none of the studies evaluated ADHD symptoms on and off methylphenidate, there was no way to link the changes in brain activation with clinical improvement.  Brain activation patterns with methylphenidate differed for patients who were versus were not previously treated with stimulants for ADHD.

Patients with ADHD have “age-inappropriate frequency or severity of inattentive or hyperactive-impulsive behaviors,” according to the authors.  It affects about five percent of children worldwide, and a growing body of evidence suggests that ADHD persists throughout adolescence and into adulthood.  Functional fMRI provides a safe, noninvasive way to study how stimulants like methylphenidate may act in the brain of ADHD patients.

The new analysis suggests that methylphenidate partially normalizes activation in key brain areas thought to be involved in ADHD.  The studies “may provide evidence that methylphenidate facilitates the return of brain function in ADHD patients to, or close to, a typically functioning state,” Dr Moore and colleagues write.  They call for further research to confirm that methylphenidate-induced changes in specific brain areas are correlated with improvement in ADHD symptoms.

About the Harvard Review of Psychiatry

The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer-reviewed and not industry sponsored. It is the property of Harvard University and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals.  Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Psychiatry, Psychology and Addiction Medicine, Publications | Leave a comment

Study Supports Alternative Model for Personality Disorders in Upcoming DSM-5

‘Appreciable Correspondence” Between DSM-IV and DSM-5 Alternative Model for Personality Disorder Diagnoses, Reports Journal of Psychiatric Practice

Philadelphia, Pa.  (May 10, 2013) – A new “alternative model” included in the upcoming Fifth Edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM -5) lines up well with the current approach to diagnosis of personality disorder, according to a study in the May Journal of Psychiatric Practice.  The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The findings lend support to the new “hybrid” model, which combines the “core” dimensions of personality disorder with various maladaptive personality traits found in individual patients, according to the report by Leslie C.  Morey, PhD, of Texas A & M University and Andrew E.  Skodol, MD, of the University of Arizona College of Medicine and Columbia University College of Physicians and Surgeons. 

Hybrid Model Compares Well with DSM-IV Diagnosis of Personality Disorders

Experts working on the long-awaited DSM-5—to be published later this month—recommended substantial revisions to the section on personality disorders.  Specifically, they proposed a “hybrid categorical-dimensional model” including not only “core impairments in personality functioning” but also various combinations of “pathological personality traits” associated with these conditions.   Goals of the proposal included:

  • Reducing overlap among personality disorder diagnoses
  • Reducing heterogeneity among patients receiving the same diagnosis
  • Eliminating arbitrary diagnostic thresholds with little or no research basis
  • Addressing the widespread use of the vague “personality disorder not otherwise specified” diagnosis
  • Providing diagnostic thresholds that are related to level of impairment in a meaningful way

Although the proposal was endorsed by the DSM-5 Task Force, it was decided that the hybrid model required more research support before being fully adopted.  Therefore, the hybrid model will be referred to as an “alternative model” and placed in Section III of the DSM-5, which contains concepts for which further research is needed.   Meanwhile, the main body of the DSM-5 will retain the DSM-IV criteria for personality disorders.

A key concern was whether the new model would lead to discrepancies between DSM-IV and DSM-5 definitions of the same disorder—especially for diagnoses such as borderline, antisocial, and schizotypal personality disorders for which a substantial body of research literature exists.   “It is important to evaluate whether thresholds can be established that provide solid continuity between DSM-IV and proposed DSM-5 definitions,” Drs Morey and Skodol write.

Their study included a national sample of 337 patients, who were diagnosed under both systems by clinicians familiar with their cases.  The results showed appreciable correspondence between the DSM-IV diagnosis of personality disorders and the hybrid categorical-dimensional diagnostic model proposed for DSM-5.   The two models agreed well for various subtypes, including borderline, avoidant, obsessive-compulsive, antisocial, narcissistic, and schizotypal personality disorders. 

“[T]raditional DSM-IV categories of personality disorder can be rendered in terms of core impairments in personality functioning and pathological personality traits with high fidelity,” Drs Morey and Skodol conclude.   They believe their findings “should allay fears that translating PDs into personality functioning and trait terms will be disruptive to clinical practice or research.”

The researchers add, “[T]he definition of all personality disorders in terms of core impairments in personality functioning and pathological personality traits identifies personality pathology with high sensitivity and specificity and utility for treatment planning and prognosis.”   If their results are borne out by future studies using other methods and samples, Drs Morey and Skodol believe their findings support adopting the new categorical-dimensional model for clinical diagnosis. 

About Journal of Psychiatric Practice

Journal of Psychiatric Practice®, a peer reviewed journal, publishes reports on new research, clinically applicable reviews, articles on treatment advances, and case studies, with the goal of providing practical and informative guidance for clinicians.  Mental health professionals will want access to this journal­—for sharpening their clinical skills, discovering the best in treatment, and navigating this rapidly changing field.  John M.  Oldham, MD, is the editor in chief and past president of the American Psychiatric Association.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Psychiatry, Psychology and Addiction Medicine, Publications | Leave a comment

Spinal ‘Spacer’ Procedure Has Fewer Complications, but Higher Risk of Repeat Surgery

Less-Invasive Option for Spinal Stenosis Poses ‘Trade-Off’ in Outcomes, Reports Study in Spine

Philadelphia, Pa. (May 7, 2013) – Interspinous spacer implantation—a less-invasive alternative surgical option for spinal stenosis—has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine.  The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

However, patients receiving interspinous spacers are more likely to require repeated back surgery, according to the report by Dr Ricard A. Deyo and colleagues of Oregon Health & Science University, Portland.  They conclude, “Use of interspinous spacers poses a trade-off in outcomes:  fewer complications for the index operation, but higher rates of subsequent lumbar surgery.”

Spacers for Spinal Stenosis Have Lowest Complication Rate…

The researchers compared the outcomes of three alternatives for surgical treatment of spinal stenosis in the lower (lumbar) spine.  Patients with spinal stenosis have narrowing of the spinal canal, causing back pain, leg pain, and other symptoms.

The study included Medicare data on more than 99,000 Medicare patients, average age 75, who underwent surgery for spinal stenosis from 2006 to 2009.  Of these, about 6,000 underwent implantation of interspinous spacers—small devices placed between vertebrae to control motion in the area affected by spinal stenosis.

Outcomes were compared with approximately 17,000 patients who underwent spinal fusion surgery to join two vertebrae together and 76,000 who underwent a simpler procedure (laminectomy) to take pressure of the spinal cord (decompression).  Some patients received spacers combined with decompression.

The results showed that patients treated with spacers only had the lowest rate of major medical complications:  1.2 percent, compared to 1.8 percent with decompression and 3.3 percent with spinal fusion.  Patients receiving spacers alone also spent less time in the hospital:  average 1.4 days versus 2.7 days in the decompression group. 

…But Higher Rate of Repeated Spinal Surgery

“Although patients receiving spacers had the lowest rate of complications, they had the highest rate of revision surgery,” Dr Deyo and coauthors write.  Within two years, about 17 percent of patients receiving spacers needed an additional operation on the lumbar spine, compared to 8.5 percent in the laminectomy group and about 10 percent in the fusion group.

Patients receiving spacers tended to be older and to have other medical problems.  With adjustment for these and other factors, patients in the spacer group were more than twice as likely to require repeat surgery.  “Hospital payments for spacer surgery were greater for decompression alone, but less than for fusion procedures,” the researchers write.

Previous studies have found that interspinous spacers are an effective treatment for patients with lumbar spinal stenosis, compared to nonsurgical care.  However, no studies have directly compared the outcomes of interspinous spacers with other surgical procedures for spinal stenosis.

Since spacer implantation is less-invasive, it’s not surprising to learn that it has a lower complication than more extensive surgical procedures.  However, the new results suggest that spacers carry a “substantially greater likelihood” of requiring further surgery later on.

The authors discuss the trade-offs among complications, costs, and repeat surgery.  For patients at average risk, “the higher reoperation rate with spacers may argue in favor of conventional decompression surgery,” the researchers write.  Spacers might be a good alternative for older patients with higher surgical risks.

Dr Deyo and coauthors note some important limitations of their study—particularly the lack of data on pain relief or functional recovery.  They highlight the need for further research, including studies comparing the cost=effectiveness of spacers versus other options.  “Only with such additional study will the optimal indications for this new technology become clear,” they write.

About Spine

Recognized internationally as the leading journal in its field, Spine (www.spinejournal.com) is an international, peer-reviewed, bi-weekly periodical that considers for publication original articles in the field of spine. It is the leading subspecialty journal for the treatment of spinal disorders. Only original papers are considered for publication with the understanding that they are contributed solely to Spine.  According to the latest ISI Science Citation Impact Factor, Spine is the most frequently cited spinal deformity journal among general orthopaedic journals and subspecialty titles.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes.

LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2012 annual revenues of €3.6 billion ($4.6 billion).

Contacts:

Robert Dekker
Director of Communications
Wolters Kluwer Health
+1 (215) 521-8928
Robert.Dekker@wolterskluwer.com

Connie Hughes
Director, Marketing Communications
Wolters Kluwer Health Medical Research
+1 (646) 674-6348
Connie.Hughes@wolterskluwer.com

Posted in All Medicine, Neurology, Orthopedics, Publications, Surgery - General, Surgery - Neurosurgery | Leave a comment